Drug intelligence / Profile preview

Peiyuan Mingmu Pills

Development stage
Unknown
Lead developer
Eye Hospital, China Academy of Chinese Medical Sciences
Administration
Oral
01

Overview

Peiyuan Mingmu Pills is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Eye Hospital of the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of retinitis pigmentosa (RP), a group of rare genetic disorders that involve a breakdown and loss of cells in the retina. In TCM theory, the drug is targeted at patients with the liver–kidney yin deficiency pattern. Clinical evaluation, including a Phase 0 trial in China, has focused on its ability to improve or stabilize the visual field, visual acuity, and electroretinogram (ERG) responses in adult patients. As a complex herbal mixture, its mechanism involves multi-target effects aimed at neuroprotection and improving ocular microcirculation.

Brand names
Peiyuan Mingmu Pills
Other names
Peiyuan Mingmu Wan

Beyond the preview

Go deeper on Peiyuan Mingmu Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peiyuan Mingmu Pills.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call